Completed PHASE4 INTERVENTIONAL 1-arm NCT04090346

Fecal Microbiota Transplant

Sponsor: Methodist Health System

Conditions Clostridium Difficile Infection

Interventions Fecal Microbiota Transplant

Updated 7 times since 2019 Last updated: Mar 26, 2024 Started: Jun 5, 2018 Primary completion: Mar 30, 2022 Completion: Mar 30, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04090346, this PHASE4 trial focuses on Clostridium Difficile Infection and remains completed. Sponsored by Methodist Health System, it has been updated 7 times since 2018, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Apr 2024 — Jul 2024 [monthly]

Completed PHASE4

Status: Enrolling By Invitation → Completed
Dec 2021 — Apr 2024 [monthly]

Enrolling By Invitation PHASE4
Jan 2021 — Dec 2021 [monthly]

Enrolling By Invitation PHASE4

▶ Show 2 earlier versions

Feb 2020 — Jan 2021 [monthly]

Enrolling By Invitation PHASE4
Oct 2019 — Feb 2020 [monthly]

Enrolling By Invitation PHASE4

First recorded

Jun 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Methodist Health System

Data source: Methodist Health System

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dallas, United States